Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Recurrent Langerhans Cell Histiocytosis
New York, New York
Recurrent Langerhans Cell Histiocytosis Clinical Trials in New York, New York
1 recruiting
New York, New York
Showing
1–1
of
1
trials
Recruiting
Phase 2
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis
Refractory Langerhans Cell Histiocytosis
National Cancer Institute (NCI)
48 enrolled
117 locations
NCT05828069
Feedback